# Study Evaluating Effexor XR in Elderly Patients With Major Depression.

> **NCT00225485** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 100 (—)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Effexor XR

## Key facts

- **NCT ID:** NCT00225485
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (—)
- **Last updated:** 2007-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225485, "Study Evaluating Effexor XR in Elderly Patients With Major Depression.". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00225485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*